⁎ Corresponding author. Masih Daneshvari Hospital, Darabad, Niavaran Tehran, Iran. E-mail address: s.mirzendehdel@gmail.com (S. Mirzendehdel). Understanding the prevalence of HIV and HPV infection among drug-addictedwomen and detecting high-risk HPV types could lead to integration of prevention and treatment into public health planning. This cross-sectional study of HPV and HIV prevalence was performed between 2007 and 2008 among women attending a drop-in center in Southern Tehran, Iran, that provides food and methadone to drugaddictedwomen.All addictedwomenattending the centerwere included in the study. All study participants were interviewed and their method of drug use was determined. After obtaining consent, a gynecological exam was conducted and a cervical swab sample was obtained for laboratory studies. If participants had vaginal discharge or there was clinical suspicion of pelvic infection, appropriate tests and treatment were provided. A 2 mL-sample of blood was obtained from the study participants and tested for HIV using an ELISA test (Adaltis Inc, Montreal, Canada). Positive screens were followed by western blot for confirmation. If test results were positive for HIV, referral was made to specialty clinics for further evaluation and possible treatment. Cervical swabs and scrapes obtained for HPV detection in all cases were transferred into tubes and transported at 8°C to the Virology Research Center of the National Research Institute of Tuberculosis and Lung Disease, Tehran. At the laboratory the cervical samples were resuspended in 500 μL of phosphate-buffered saline, immediately centrifuged, and the pellet was stored at −70 °C until further processing. For detection of HPV genotypes, nested polymerase chain reaction (PCR) analysis was performed using MY09/MY11 as the outer primers and GP5+/GP6+ as the inner primers, as previously described and with minor modification [1]. The positive samples were genotyped using a GP-E6/E7 nested multiplexPCRassay [1].HPVgenotypesweredivided into3groups: highrisk genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68); lowrisk genotypes (6–11, 42, 43, 44); and genotypes that could not be identified. The study protocol was approved by the scientific and ethics committee of the National Research Institute of Tuberculosis and Lung disease, Tehran. Data were analyzed using SPSS version 15.0 (SPSS, Chicago, IL, USA). Continuous variables were expressed as group means±SD. The χ test without Yates correction and a Fisher exact test were used as appropriate. All reported P values are two-sided. Pb0.05was considered statistically significant. Multivariate logistic regression was used to determine the independent risk factors for HPV and high-risk genotypes. A total of 118 women were included in the study. The average age of the participants was 35.06±1.16 years (range, 15–61 years). There were 15participantswithahistoryof intravenousdruguse.A total of 91 (77.1%) women had a history of crack cocaine use. Ten (8.5%) participants had a history of crack cocaine abuse and intravenous drug use. A total of 29 (24.6%) women had multiple sexual partners. Five (4.2%) women were unmarried, 51 (43.2%) were married, 51 (43.2%) were divorced, and 11 (9.3%) were widowed. Seventeen (14.4%) women were illiterate, 89 (75.4%) had a level of education below diploma level, and 12 (10.2%) participants had a diploma or higher level of education. Vaginal discharge was reported by 64 (54.2%) women. Candidiasis was found in 22 (18.6%) women and discharge caused by other infection was found in 44 (35.6%) participants. A total of 8 participants (6.8%) tested positive for HIV. The vaginal swab samples of 59 (50%)women testedpositive forHPV. More than one type of HPV virus was identified in 16 (13.6%) women. There were 26 (22%) cases of high-risk HPV, 9 (7.6%) cases of both high-
Read full abstract